Physician profile
Tom E Kettler
NPI 1285621615
$5,690.16
in general payments reported to CMS, 2019-2025
36 companies · $505 in 2025
The $505 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $455 · 2020: $1,081 · 2021: $1,067 · 2022: $779 · 2023: $999 · 2024: $804 · 2025: $505.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,307.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $928.69 | 2019-2025 | |
| Novo Nordisk INC | $730.85 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $547.44 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $477.72 | 2019-2025 | Evenity, Prolia |
| Astrazeneca Pharmaceuticals Lp | $381.93 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $293.24 | 2019-2025 | Xifaxan |
| Amarin Pharma, INC. | $273.84 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $267.98 | 2021-2024 | Ajovy, Austedo Xr, Austedo |
| Boston Scientific Corporation | $230.11 | 2019-2024 | Resolution 360 Clip, Watchman Flx |
| Kowa Pharmaceuticals America, INC. | $225.20 | 2019-2025 | Zoryve, Livalo |
| Glaxosmithkline, LLC. | $176.16 | 2020-2023 | Shingrix, Arexvy |
| Idorsia Pharmaceuticals US INC | $135.26 | 2023 | Quviviq |
| Abbott Laboratories | $102.70 | 2022-2025 | Freestyle Libre 2, Freestyle Libre 3 |
| Antares Pharma, INC. | $101.27 | 2020-2021 | |
| Pfizer INC. | $79.14 | 2023-2024 |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tom Kettler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.